LACEY MORRIS: Open Payments
NPI 1619063161 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$141 in 7 payments from 4 companies in 2025. Trend: 2023 $105 · 2024 $20 · 2025 $141
Food & beverage: $141
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: INVEGA SUSTENNA, INGREZZA, UZEDY, Veozah.
Industry payments across LA — which companies pay providers there.
